Kyprolis (Carfilzomib)
$2,619.91
60mg Sol Inyectable Caja C/1 ámpula
... people are viewing this right now
Carfilzomib, sold under the brand name Kyprolis, is an anti-cancer medication acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin.
Reviews
There are no reviews yet.